Search Results - "HO KEUNG NG"
-
1
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
Published in Brain pathology (Zurich, Switzerland) (01-09-2014)“…Major discoveries in the biology of nervous system tumors have raised the question of how non‐histological data such as molecular information can be…”
Get full text
Journal Article -
2
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
Published in Brain pathology (Zurich, Switzerland) (01-05-2020)“…In the 2016, WHO classification of tumors of the central nervous system, isocitrate dehydrogenase (IDH) mutation is a main classifier for lower grade…”
Get full text
Journal Article -
3
Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells
Published in Nature medicine (01-08-2018)“…The failure to develop effective therapies for pediatric glioblastoma (pGBM) and diffuse intrinsic pontine glioma (DIPG) is in part due to their intrinsic…”
Get full text
Journal Article -
4
TP53 and Histone H3.3 Mutations in Triple-Negative Lower-Grade Gliomas
Published in The New England journal of medicine (01-12-2016)“…Deletion of chromosome arms 1p and 19q and mutations in IDH and TERT define prognostic subgroups of low-grade gliomas. Gliomas without these lesions…”
Get full text
Journal Article -
5
Prognostic impact of distinct genetic entities in pediatric diffuse glioma WHO‐grade II—Report from the German/Swiss SIOP‐LGG 2004 cohort
Published in International journal of cancer (15-10-2020)“…Reports on pediatric low‐grade diffuse glioma WHO‐grade II (DG2) suggest an impaired survival rate, but lack conclusive results for genetically defined…”
Get full text
Journal Article -
6
Molecular landscape of IDH‐wild‐type, H3‐wild‐type glioblastomas of adolescents and young adults
Published in Neuropathology and applied neurobiology (01-06-2022)“…Objective We aimed to characterise glioblastomas of adolescents and young adults (AYAs) that were isocitrate dehydrogenase (IDH) wild type (wt) and H3wt…”
Get full text
Journal Article -
7
Whole‐exome sequencing revealed mutational profiles of giant cell glioblastomas
Published in Brain pathology (Zurich, Switzerland) (01-11-2019)“…Giant cell glioblastoma (gcGBM) is a rare histological variant of GBM, accounting for about 1% of all GBM. The prognosis is poor generally though gcGBM does…”
Get full text
Journal Article -
8
MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3)
Published in Brain pathology (Zurich, Switzerland) (01-07-2013)“…Accumulating evidence suggests that microRNAs (miRNAs) are over‐ or under‐expressed in tumors, and abnormalities in miRNA expression may contribute to…”
Get full text
Journal Article -
9
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
Published in Acta neuropathologica (01-05-2021)“…Recent genomic studies have shed light on the biology and inter-tumoral heterogeneity underlying pineal parenchymal tumors, in particular pineoblastomas (PBs)…”
Get full text
Journal Article -
10
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
Published in Modern pathology (01-07-2021)“…WHO 2016 classified glioblastomas into IDH-mutant and IDH-wildtype with the former having a better prognosis but there was no study on IDH-mutant primary…”
Get full text
Journal Article -
11
Molecular landscape of IDH‐wild type, pTERT‐wild type adult glioblastomas
Published in Brain pathology (Zurich, Switzerland) (01-11-2022)“…Telomerase reverse transcriptase (TERT) promoter (pTERT) mutation has often been described as a late event in gliomagenesis and it has been suggested as a…”
Get full text
Journal Article -
12
miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1
Published in Human pathology (01-09-2009)“…Summary Given that miR-124 is preferentially expressed in differentiating and mature neurons and external granule cells of cerebellum are thought to be…”
Get full text
Journal Article -
13
Expanding the clinical and molecular spectrum of pituitary blastoma
Published in Acta neuropathologica (01-03-2022)Get full text
Journal Article -
14
Clinical and mutational profiles of adult medulloblastoma groups
Published in Acta neuropathologica communications (10-11-2020)“…Adult medulloblastomas are clinically and molecularly understudied due to their rarity. We performed molecular grouping, targeted sequencing, and TERT promoter…”
Get full text
Journal Article -
15
Non-mitotic proliferation of malignant cancer cells revealed through live-cell imaging of primary and cell-line cultures
Published in Cell division (10-02-2024)“…Anti-mitosis has been a key strategy of anti-cancer therapies, targeting at a fundamental property of cancer cells, their non-controllable proliferation due to…”
Get full text
Journal Article -
16
Molecular landscapes of longitudinal NF2/22q and non‐NF2/22q meningiomas show different life histories
Published in Brain pathology (Zurich, Switzerland) (01-05-2023)“…Recurrence is a major complication of some meningiomas. Although there were many studies on biomarkers associated with higher grades or increased…”
Get full text
Journal Article -
17
Pediatric low-grade gliomas can be molecularly stratified for risk
Published in Acta neuropathologica (01-10-2018)“…Pediatric low-grade gliomas (PLGGs) consist of a number of entities with overlapping histological features. PLGGs have much better prognosis than the adult…”
Get full text
Journal Article -
18
Clinical significance of vasculogenic mimicry in human gliomas
Published in Journal of neuro-oncology (01-11-2011)“…Vasculogenic mimicry (VM) is known as non-endothelial tumor cell-lined microvascular channels in aggressive tumors. We have previously found the presence of VM…”
Get full text
Journal Article -
19
Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma
Published in Frontiers in oncology (02-10-2020)“…The 2016 WHO classification of central nervous system tumors has included four molecular subgroups under medulloblastoma (MB) as sonic hedgehog (SHH), wingless…”
Get full text
Journal Article -
20